Current Editions
After huge day, more follow-ons lift week’s total to nearly $4.5B: Public Equity Report
Plus: More companies queue up for Hong Kong listings as Shanghai Bao enjoys first-day stock bump
Finance
Product Development
BeOne strengthens its BTK position at ASH
BeOne reports six-year data from Brukinsa in front-line CLL and early results from a BTK degrader that anchors a broader protein degradation strategy
Editor's Commentary
Makary’s embrace of ideology, conspiracies puts FDA at risk: A Perspective
Because the FDA commissioner is making regulatory decisions, his views about scientific evidence are concerning
Data Byte
EMA’s CHMP backs new medicines from Hansoh, Cytokinetics
Five new drugs and vaccines recommended at committee’s December meeting
Management Tracks
CEO moves at Prolynx, Centessa, Kyowa Kirin, Enliven, Expression
Plus: New CFOs for Valo Health, SciNeuro — and more
BioCentury ISSN 1097-7201